PCM
CCXI

Penserra Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Penserra Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,600
Closed -$27K – 1626
2021
Q3 		$27K Buy
1,600
+10
+0.6% +$156 ﹤0.01% 1204
2021
Q2 		$21K Buy
1,590
+25
+2% +$616 ﹤0.01% 1141
2021
Q1 		$80K Sell
1,565
-25
-2% -$1.5K ﹤0.01% 729
2020
Q4 		$98K Buy
1,590
+1,000
+169% +$57.3K ﹤0.01% 607
2020
Q3 		$32K Buy
+590
New +$31.8K ﹤0.01% 683

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penserra Capital Management's CCXI Position: Q4 2021 in Review

Penserra Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2021, closing a stake of 1,600 shares — an estimated $27K sold.

Penserra Capital Management first reported a position in CCXI in Q3 2020 and held it in 5 quarters. The position peaked at $98K in Q4 2020. 190 funds tracked by Wall St. Rank hold CCXI as of Q4 2021.

  • Penserra Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,600 ChemoCentryx, Inc. shares in Q4 2021, an estimated $27K.
  • Penserra Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's ChemoCentryx, Inc. position peaked at $98K in Q4 2020.
  • 190 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.